Zara Sheikh1, Ekpemi Irune2. 1. Department of Otolaryngology, Head and Neck Surgery, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. zarasheikh@nhs.net. 2. Department of Otolaryngology, Head and Neck Surgery, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.
Abstract
PURPOSE: Day-case thyroid surgery has been endorsed by the American Thyroid Association and the British Association of Day Surgery. Despite the many benefits of day surgery, day-case thyroid surgery is not widely practiced. We describe the use of sensitivity analysis modelling and cost analysis in determining and refining the patient cohort that safely meet the threshold for a new day-case thyroid lobectomy service at a tertiary referral head and neck centre. METHODS: All cases of first-time thyroid lobectomy were identified between 2015 and Q2 2019. Patients suitable for day-case thyroid lobectomy were identified retrospectively, according to the following criteria: Age < 65 years, ASA grade < 3, BMI < 30 kg/m2 and distance from tertiary unit < / = 30 min. Sensitivity analysis was undertaken, manipulating each parameter in turn to assess the effect on eligibility and associated cost-savings. RESULTS: 259 Thyroid lobectomy procedures were performed, 173 of these met inclusion criteria. Sensitivity analysis revealed that after increasing all day-case parameters by four increments, eligibility increased from 47 (27%) to 112 patients (64.7%), with only one outpatient to inpatient conversion. Multivariate logistical regression analysis found that age was the only variable to increase the risk of adverse outcomes (OR = 1.10, p < 0.05). Using data from the NHS reference costs, if 60% of all thyroid lobectomies nationally were undertaken as day-case, this would have amounted to savings of £26.3 m over five years. CONCLUSION: Through sensitivity analysis, we determined that we could safely offer day-case thyroid lobectomy to 64.7% of our patient cohort.
PURPOSE: Day-case thyroid surgery has been endorsed by the American Thyroid Association and the British Association of Day Surgery. Despite the many benefits of day surgery, day-case thyroid surgery is not widely practiced. We describe the use of sensitivity analysis modelling and cost analysis in determining and refining the patient cohort that safely meet the threshold for a new day-case thyroid lobectomy service at a tertiary referral head and neck centre. METHODS: All cases of first-time thyroid lobectomy were identified between 2015 and Q2 2019. Patients suitable for day-case thyroid lobectomy were identified retrospectively, according to the following criteria: Age < 65 years, ASA grade < 3, BMI < 30 kg/m2 and distance from tertiary unit < / = 30 min. Sensitivity analysis was undertaken, manipulating each parameter in turn to assess the effect on eligibility and associated cost-savings. RESULTS: 259 Thyroid lobectomy procedures were performed, 173 of these met inclusion criteria. Sensitivity analysis revealed that after increasing all day-case parameters by four increments, eligibility increased from 47 (27%) to 112 patients (64.7%), with only one outpatient to inpatient conversion. Multivariate logistical regression analysis found that age was the only variable to increase the risk of adverse outcomes (OR = 1.10, p < 0.05). Using data from the NHS reference costs, if 60% of all thyroid lobectomies nationally were undertaken as day-case, this would have amounted to savings of £26.3 m over five years. CONCLUSION: Through sensitivity analysis, we determined that we could safely offer day-case thyroid lobectomy to 64.7% of our patient cohort.
Entities:
Keywords:
Ambulatory surgical procedures; Cost analysis; Day-case thyroid surgery; Health access; Outpatient thyroid surgery
Authors: C R Bailey; M Ahuja; K Bartholomew; S Bew; L Forbes; A Lipp; J Montgomery; K Russon; O Potparic; M Stocker Journal: Anaesthesia Date: 2019-04-08 Impact factor: 6.955
Authors: Blake C Alkire; Nakul P Raykar; Mark G Shrime; Thomas G Weiser; Stephen W Bickler; John A Rose; Cameron T Nutt; Sarah L M Greenberg; Meera Kotagal; Johanna N Riesel; Micaela Esquivel; Tarsicio Uribe-Leitz; George Molina; Nobhojit Roy; John G Meara; Paul E Farmer Journal: Lancet Glob Health Date: 2015-04-27 Impact factor: 26.763
Authors: Samuel K Snyder; Kamran S Hamid; Charles R Roberson; Surjit S Rai; Adam C Bossen; Jeffery H Luh; Elizabeth P Scherer; Juhee Song Journal: J Am Coll Surg Date: 2010-05 Impact factor: 6.113
Authors: C Lacroix; G Potard; C Clodic; E Mornet; G Valette; R Marianowski Journal: Eur Ann Otorhinolaryngol Head Neck Dis Date: 2013-10-26 Impact factor: 2.080
Authors: Paulo Lemos; Ana Pinto; Gustavo Morais; José Pereira; Rui Loureiro; Sofia Teixeira; Catarina S Nunes Journal: J Clin Anesth Date: 2009-05 Impact factor: 9.452
Authors: Stéphane Verguet; Blake C Alkire; Stephen W Bickler; Jeremy A Lauer; Tarsicio Uribe-Leitz; George Molina; Thomas G Weiser; Gavin Yamey; Mark G Shrime Journal: Lancet Glob Health Date: 2015-04-27 Impact factor: 26.763
Authors: Rupert M Pearse; Rui P Moreno; Peter Bauer; Paolo Pelosi; Philipp Metnitz; Claudia Spies; Benoit Vallet; Jean-Louis Vincent; Andreas Hoeft; Andrew Rhodes Journal: Lancet Date: 2012-09-22 Impact factor: 79.321